| Dendritic cell-based nanovaccines for cancer immunotherapy LE Paulis, S Mandal, M Kreutz, CG Figdor Current opinion in immunology 25 (3), 389-395, 2013 | 172 | 2013 |
| Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study F Sousa, S Mandal, C Garrovo, A Astolfo, A Bonifacio, D Latawiec, ... Nanoscale 2 (12), 2826-2834, 2010 | 147 | 2010 |
| Nucleotide reverse transcriptase inhibitors: a thorough review, present status and future perspective as HIV therapeutics AD Holec, S Mandal, PK Prathipati, CJ Destache Current HIV research 15 (6), 411-421, 2017 | 131 | 2017 |
| Therapeutic nanoworms: towards novel synthetic dendritic cells for immunotherapy S Mandal, ZH Eksteen-Akeroyd, MJ Jacobs, R Hammink, M Koepf, ... Chemical Science 4 (11), 4168-4174, 2013 | 122 | 2013 |
| Poly-l-lysine-Coated Silver Nanoparticles as Positively Charged Substrates for Surface-Enhanced Raman Scattering L Marsich, A Bonifacio, S Mandal, S Krol, C Beleites, V Sergo Langmuir 28 (37), 13166-13171, 2012 | 107 | 2012 |
| Overview of nano-drugs characteristics for clinical application: the journey from the entry to the exit point T Bose, D Latawiec, PP Mondal, S Mandal Journal of nanoparticle research 16, 1-25, 2014 | 89 | 2014 |
| Electrophoretic characterization of gold nanoparticles functionalized with human serum albumin (HSA) and creatine J López-Viota, S Mandal, AV Delgado, JL Toca-Herrera, M Möller, ... Journal of Colloid and Interface Science 332 (1), 215-223, 2009 | 87 | 2009 |
| Controlling T-cell activation with synthetic dendritic cells using the multivalency effect R Hammink, S Mandal, LJ Eggermont, M Nooteboom, PHGM Willems, ... ACS omega 2 (3), 937-945, 2017 | 68 | 2017 |
| Polymer-based synthetic dendritic cells for tailoring robust and multifunctional T cell responses S Mandal, R Hammink, J Tel, ZH Eksteen-Akeroyd, AE Rowan, K Blank, ... ACS Chemical Biology 10 (2), 485-492, 2015 | 62 | 2015 |
| Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission S Mandal, PK Prathipati, G Kang, Y Zhou, Z Yuan, W Fan, Q Li, ... Aids 31 (4), 469-476, 2017 | 55 | 2017 |
| Design, development and characterization of multi-functionalized gold nanoparticles for biodetection and targeted boron delivery in BNCT applications S Mandal, GJ Bakeine, S Krol, C Ferrari, AM Clerici, C Zonta, L Cansolino, ... Applied Radiation and Isotopes 69 (12), 1692-1697, 2011 | 48 | 2011 |
| Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against … S Mandal, G Kang, PK Prathipati, Y Zhou, W Fan, Q Li, CJ Destache Journal of controlled release 294, 216-225, 2019 | 45 | 2019 |
| An enhanced Emtricitabine loaded long-acting nano-formulation for prevention or treatment of HIV infection. S Mandal, M Belshan, A Holec, Y Zhou, CJ Destache Antimicrob Agents Chemother 61 (1), e01475-16., 2016 | 45 | 2016 |
| Topical tenofovir disoproxil fumarate nanoparticles prevent HIV-1 vaginal transmission in a humanized mouse model CJ Destache, S Mandal, Z Yuan, G Kang, AA Date, W Lu, A Shibata, ... Antimicrobial agents and chemotherapy 60 (6), 3633-3639, 2016 | 45 | 2016 |
| Long-acting parenteral combination antiretroviral loaded nano-drug delivery system to treat chronic HIV-1 infection: A humanized mouse model study S Mandal, G Kang, PK Prathipati, W Fan, Q Li, CJ Destache Antiviral research 156, 85-91, 2018 | 43 | 2018 |
| Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection AN Pandya, PK Prathipati, P Hegde, W Li, KF Graham, S Mandal, ... Antimicrobial agents and chemotherapy 63 (3), 10.1128/aac. 02245-18, 2019 | 41 | 2019 |
| Simultaneous quantification of tenofovir, emtricitabine, rilpivirine, elvitegravir and dolutegravir in mouse biological matrices by LC–MS/MS and its application to a … PK Prathipati, S Mandal, CJ Destache Journal of pharmaceutical and biomedical analysis 129, 473-481, 2016 | 41 | 2016 |
| A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study S Mandal, PK Prathipati, M Belshan, CJ Destache Antiviral research 167, 83-88, 2019 | 40 | 2019 |
| Pharmacokinetic and tissue distribution profile of long acting tenofovir alafenamide and elvitegravir loaded nanoparticles in humanized mice model PK Prathipati, S Mandal, G Pon, R Vivekanandan, CJ Destache Pharmaceutical research 34, 2749-2755, 2017 | 37 | 2017 |
| A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles HNA Tran, F Sousa, F Moda, S Mandal, M Chanana, C Vimercati, ... Nanoscale 2 (12), 2724-2732, 2010 | 36 | 2010 |
Pavan Kumar Prathipati, PhD, MBASenior ScientistVerified email at q2labsolutions.com
